CCL5 and nonpapillary renal cell carcinoma: To validate the remarkable differential status of TIME in relation to CCL5 expression, a FCM assay was performed on 30 fresh ccRCC tumor tissues to assess the impact of intra-tumoral CCL5+ TAMs on TME functions.